Your browser doesn't support javascript.
loading
What do Cochrane systematic reviews say about diabetic retinopathy?
São Paulo med. j ; 135(1): 79-87, 2017.
Artigo em Inglês | Sec. Est. Saúde SP, SESSP-IDPCPROD, Sec. Est. Saúde SP | ID: ses-37339
Biblioteca responsável: BR79.1
Localização: BR79.1
ABSTRACT
CONTEXT AND

OBJECTIVE:

Diabetic retinopathy is a disease caused by increased permeability of retinal vessels. Its incidence and prevalence have been increasing due to urbanization, greater life expectancy and the habits of modern life. Its onset is insidious and it may lead to blindness in 75% of individuals who have been diabetic for more than 20 years. The aim here was to evaluate the evidence from Cochrane systematic reviews on interventions relating to diabetic retinopathy.DESIGN AND

SETTING:

Review of systematic reviews, conducted at Cochrane Brazil.

METHODS:

We included Cochrane systematic reviews on interventions relating to diabetic retinopathy. Two researchers evaluated the inclusion criteria, summarized the reviews and presented the results narratively.

RESULTS:

Ten reviews met the inclusion criteria. They showed some evidence of benefits from (a) photocoagulation for diabetic retinopathy; (b) strict glucose and pressure control for postponing the onset of retinopathy; (c) antiangiogenic drugs for macular edema (high-quality evidence); (d) anti-vascular endothelial growth factor agents for proliferative diabetic retinopathy (very low to low-quality evidence); and (e) intravitreal injection or surgical implantation for treating persistent or refractory macular edema. However, blood pressure control seems to have no benefit after the onset of retinopathy. (AU)
Assuntos

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponível Coleções: Bases de dados nacionais / Brasil Base de dados: Sec. Est. Saúde SP / SESSP-IDPCPROD Assunto principal: Retinopatia Diabética / Medicina Limite: Humanos Idioma: Inglês Revista: São Paulo med. j Ano de publicação: 2017 Tipo de documento: Artigo Instituição/País de afiliação: Cochrane Brazil/Brazil / Escola Paulista de Medicina (EPM)/Brazil / Hospital Dante Pazzanese de Cardiologia/Brazil / Universidade Federal de São Paulo/Brazil